Bone Biologics Corp

Editas Medicine, headquartered in Cambridge, Massachusetts, is a pioneering biotechnology company focused on leveraging CRISPR gene editing technology to develop transformative therapies for patients. The company went public on February 3, 2016, and is traded on the NASDAQ Global Market under the ticker symbol EDIT. With a commitment to innovation, Editas Medicine aims to advance genetic medicine through its robust research pipeline and dedicated team. The company is supported by a strong network of financial and legal partnerships, ensuring its ongoing growth and adherence to regulatory standards. Generated from the website

Bicara Therapeutics Inc is a Boston-based biotechnology company focused on innovative therapeutic solutions. Their work emphasizes the intersection of science and patient care, aiming to improve treatment outcomes. The company is dedicated to advancing its scientific research to develop novel approaches that benefit patients. They also maintain a commitment to transparency and engagement with investors and career opportunities within the field. Generated from the website

Sequre DX Inc is a technology company based in Boston, MA that specializes in data encryption and secure communication solutions. With a focus on maintaining privacy and confidentiality, Sequre DX Inc offers innovative products and services to help businesses protect their sensitive information. Generated from their business information